Compare
Mountain Crest Acquisition Corp. V vs Vycor Medical Inc vs Family Office of America, Inc. vs Nuo Therapeutics, Inc.
| Latest fiscal year | Mountain Crest Acquisition Corp. V MCAG | Vycor Medical Inc VYCO | Family Office of America, Inc. FOFA | Nuo Therapeutics, Inc. AURX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $1.86M | $221.8K | $3.31M |
| Revenue growth (YoY) | n/a | +17.2% | n/a | +142.7% |
| Gross margin | n/a | 83.8% | 100.0% | 66.9% |
| Operating margin | n/a | 1.8% | -226.0% | -76.0% |
| Net margin | n/a | -3.9% | -222.2% | -75.8% |
| Net income | -$431.2K | -$72.4K | -$492.7K | -$2.51M |
| EPS (Diluted) | n/a | -$0.01 | -$0.02 | n/a |
| Operating cash flow | -$742.0K | -$13.5K | -$262.2K | -$865.0K |
| Free cash flow | n/a | -$18.7K | n/a | -$1.14M |
| Cash & equivalents | n/a | $87.0K | n/a | $548.9K |
| Total assets | $873.6K | $830.4K | $1.54M | $1.85M |
| Total liabilities | $3.72M | $4.92M | $878.5K | $2.80M |
| Shareholders' equity | -$3.68M | -$4.09M | $664.5K | -$956.6K |
| Return on year-end equity | n/a | n/a | -74.2% | n/a |
| Shares outstanding | 2.80M | 33.37M | 30.20M | 48.18M |
Revenue, most recent five fiscal years
| Fiscal year | Mountain Crest Acquisition Corp. V | Vycor Medical Inc | Family Office of America, Inc. | Nuo Therapeutics, Inc. |
|---|---|---|---|---|
| Latest | n/a | $1.86M Ended 2025-12-31 | $221.8K Ended 2025-12-31 | $3.31M Ended 2025-12-31 |
| 1 year earlier | n/a | $1.59M Ended 2024-12-31 | n/a | $1.37M Ended 2024-12-31 |
| 2 years earlier | n/a | $1.46M Ended 2023-12-31 | n/a | $608.5K Ended 2023-12-31 |
| 3 years earlier | n/a | $1.22M Ended 2022-12-31 | n/a | $112.2K Ended 2022-12-31 |
| 4 years earlier | n/a | $1.39M Ended 2021-12-31 | n/a | $0 Ended 2021-12-31 |